INTRODUCTION: Treatment of @entity1276 related to myelomeningocele (MM) is debated. Endoscopic third ventriculostomy (ETV) has been proposed with contrasting results. We report our experience in the management of @entity1276 related to MM and the advantages of ETV. MATERIAL AND METHODS: From 1994 to 2012, we treated 97 @entity1 with MM. Seventy @entity1 developed a @entity1276 needing a surgical treatment. Three types of procedures were used: ETV with concomitant @entity2846 ( @entity2846 ), ETV with concomitant ventriculoperitoneal shunt (VPS), or VPS. RESULTS: Thirty-two @entity1 had an ETV with @entity2846 , 20 @entity1 had an ETV and a concomitant VPS, and 18 @entity1 had a VPS. No perioperative complications were reported. Fifty-two @entity1 underwent an ETV. The overall success rate of ETV was approximately 70%. DISCUSSION: VPS in @entity1 with MM leads to complications. Two common arguments are reported against ETV. The first is the variability of the anatomy of the ventricle leading to possible operative complications. The second is the immaturity of the Pacchioni granulations. For us, the modified anatomy does not prevent performing ETV. Regarding the issue of cerebrospinal fluid absorption in failed ETV, the adjunction of a shunt helps to control @entity1276 until the maturation of the Pacchioni system. CONCLUSIONS: Preoperative imaging helps the surgical decision to predict in which @entity1 the ETV can be realized without risks. ETV in @entity1 with MM is a secure procedure with low rates of failure and no mortality, and it reduces the rate of shunt implantation.

Role of Endoscopic Third Ventriculostomy in the Management of Myelomeningocele-Related XXXX : A Retrospective Study in a Single French Institution.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity2846 :: ('MESH:D020288', 'Disease') :: ['choroid plexus coagulation', 'CPC'] @entity1276 :: ('MESH:D006849', 'Disease') :: ['hydrocephalus']
@entity1276 :: (MESH:D006849,Disease) :: ['Hydrocephalus']
